Discovery of 4[(2r,4r)4-({[1-(2,2-Difluoro-1,3-Benzodioxol-5-Yl)cyclopropyl]carbonyl}amino)-7-(Difluoromethoxy)-3,4-Dihydro2Hchromen-2-Yl]benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for the Treatment of Cystic Fibrosis